Shared Genetic Architecture and Causal Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density - Summary - MDSpire

Shared Genetic Architecture and Causal Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density

  • By

  • Linna Sha

  • Li Zhang

  • Xunying Zhao

  • Rong Xiang

  • Xueyao Wu

  • Jiangbo Zhu

  • Jiaojiao Hou

  • Qin Deng

  • Chenjiarui Qin

  • Changfeng Xiao

  • Yang Qu

  • Tao Han

  • Jinyu Zhou

  • Sirui Zheng

  • Ting Yu

  • Xin Song

  • Bin Yang

  • Mengyu Fan

  • Xia Jiang

  • October 21, 2024

  • 0 min

Share

Objective:

To investigate the shared genetic architecture and causal relationship between serum 25-hydroxyvitamin D (25OHD) and bone mineral density (BMD), highlighting the significance of these insights for osteoporosis risk management.

Key Findings:
  • No global genetic correlation between serum 25OHD and BMD was found (rg=−0.001; P = .95), indicating a need for further investigation into local genetic signals.
  • Significant local genetic signals identified at 5p11-5q11.9, suggesting potential areas for future research.
  • Two-sample MR indicated no causal association in the overall population (β=.003; P = .93), but positive causal effects observed in males (β=.005; P = .03) and older individuals (β=.009; P = .01).
  • Identified 49 pleiotropic SNVs, including 4 novel variants, which may have implications for understanding genetic predispositions.
  • 95 gene-tissue pairs exhibited overlap, enriched in various biological systems, highlighting the complexity of the genetic interplay.
Interpretation:

The study suggests potential health benefits of increasing serum 25OHD levels to reduce osteoporosis risk, particularly in men and older adults, while revealing a shared genetic basis between serum 25OHD and eBMD, which could inform public health strategies.

Limitations:
  • Lack of global genetic correlation may limit generalizability, necessitating caution in applying findings broadly.
  • Potential biases in observational studies could affect causal inference, underscoring the need for robust methodologies.
  • Age and sex-specific effects may not be fully accounted for in all analyses, suggesting further research is needed to clarify these relationships.
Conclusion:

Enhancing serum 25OHD levels may mitigate osteoporosis risk, with insights into the genetic interplay between vitamin D levels and bone density, emphasizing the importance of these findings for public health initiatives.

Original Source(s)

Related Content